Non-Fiction Books:

Making the Case for MTET

Where Miracles Become Standard In Oncology
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Hardback
$720.00
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
Free Delivery with Primate
Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

4 payments of $180.00 with Afterpay Learn more

6 weekly interest-free payments of $120.00 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 28 Jun - 10 Jul using International Courier

Description

Millions of cancer cases are diagnosed yearly. While a cure has yet to be discovered, one of the most promising new treatments is Multi-Targeted Epigenetic Therapy, or MTET. In Making the Case for MTET, world-renowned oncology expert Dr. Mohammad A. Nezami introduces his revolutionary method of treating patients with advanced cancer by using a careful combination of drugs and genomic sequencing. For some patients with stage four cancer, MTET has been a lifesaving intervention. Dr. Nezami presents 300 case studies of patients with advanced cancer that he treated over ten years of longitudinal tracking with MTET. Through meticulously documented data, lab reports, and full-color photographs to detailed genomic information, Dr. Nezami makes a compelling case for furthering MTET research and focusing on patient-centric care.

Author Biography:

Mohammad A. Nezami, MD, author of Transition from Crime to Care in Oncology: A Critical Review of Current Cancer Research and Its Applications, is a world-renowned authority on integrative oncology and epigenetic sciences and a graduate of the University of Southern California and University of California San Francisco residencies. He serves as the president of Medical Centers of Hope in California. He has contributed to numerous medical publications and has made presentations to such organizations as the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). Dr. Nezami, who currently teaches and consults other physicians and oncologists, is extensively involved in research and pursuing several clinical trials in integrative oncology and epigenetic sciences.
Release date NZ
March 1st, 2024
Audience
  • General (US: Trade)
Pages
574
Dimensions
216x279x41
ISBN-13
9798986347264
Product ID
38660320

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

Filed under...